Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience

<table>Kaplan-Meier survival curve comparing those with extrahepatic disease at the time of treatment versus those with disease localized to liver.  The estimated median survival was 17.0 months for those without extrahepatic disease compared to 6.7 months.  This difference was found not to be significant when using log-rank analysis, <svg height="11.175" id="M21" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 10.9375 11.175" width="10.9375" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.113)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5
t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g>
</svg><i>-</i>value of  .07.</table>

International Journal of Surgical Oncology

fig2

Figure 1

Figure 1: Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience 